Vaccine producers see bumper profits
-------------------------------------------
The four front-running vaccine-makers have seen their profits surge since the rollout of coronavirus shots, boosted by some $18.5 billion from government, public and private funding
-------------------------------------------
Vaccine income (Jan-Mar 2021) 
Taxpayer-public funding 
Private funding
Price per treatment
-------------------------------------------
AstraZeneca
$275m
$4.3-$10 (two-shot treatment)
$2.33bn
$9.22bn
-------------------------------------------
Moderna
$1.22bn
$836m
$1.84bn
$25-$37 (two-shot)
-------------------------------------------
Pfizer/BioNTech
$4.89bn
$572m
$2.60bn
$39 (two-shot) 
-------------------------------------------
Johnson & Johnson
$10 (single-shot) $6.20bn
$860m $248m

-------------------------------------------
Sources: Company reports, BBC, CNN, PublicEye, Quartz

© GRAPHIC NEWS